United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.64M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $587.00 to $597.33 a share (average $593.52) in 11 transactions, worth $5.64M in total on Nov 12, 2026. Shares held after the trade: 324,443 (-0.1%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.64M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $584.20 to $598.63 a share (average $593.99) in 14 transactions, worth $5.64M in total on Nov 11, 2026. Shares held after the trade: 324,443 (-0.1%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.57M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $577.52 to $592.93 a share (average $586.32) in 14 transactions, worth $5.57M in total on Nov 10, 2026. Shares held after the trade: 324,443 (-0.0%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $944K of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 1,614 shares of United Therapeutics Corp at $583.80 to $585.63 a share (average $584.59) in 3 transactions, worth $944K in total on Nov 9, 2026. Shares held after the trade: 324,443 (-0.1%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $4.52M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 7,886 shares of United Therapeutics Corp at $556.52 to $582.79 a share (average $572.69) in 24 transactions, worth $4.52M in total on Nov 9, 2026. Shares held after the trade: 326,057 (-0.5%).
United Therapeutics Director Christopher Patusky Sells $702K of Stock
Christopher Patusky, Director, sold 1,210 shares of United Therapeutics Corp at $580.00 a share, worth $702K in total on Nov 9, 2026. Shares held after the trade: 2,140 (-36.1%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.36M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $560.79 to $568.68 a share (average $564.51) in 9 transactions, worth $5.36M in total on Nov 6, 2026. Shares held after the trade: 324,443 (-0.0%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $1.17M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 1,950 shares of United Therapeutics Corp at $593.14 to $602.49 a share (average $597.75) in 8 transactions, worth $1.17M in total on Nov 5, 2026. Shares held after the trade: 324,443 (-0.0%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $4.33M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 7,540 shares of United Therapeutics Corp at $562.51 to $591.54 a share (average $573.89) in 24 transactions, worth $4.33M in total on Nov 5, 2026. Shares held after the trade: 326,403 (-0.0%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $1.05M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 1,723 shares of United Therapeutics Corp at $610.29 to $613.13 a share (average $611.06) in 4 transactions, worth $1.05M in total on Nov 4, 2026. Shares held after the trade: 324,443 (-0.0%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $4.66M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 7,777 shares of United Therapeutics Corp at $580.70 to $609.09 a share (average $599.64) in 24 transactions, worth $4.66M in total on Nov 4, 2026. Shares held after the trade: 326,166 (-0.4%).
United Therapeutics EVP & General Counsel Paul A. Mahon Sells $4.97M of Stock
Paul A. Mahon, EVP & General Counsel, sold 8,300 shares of United Therapeutics Corp at $593.90 to $602.72 a share (average $598.67) in 9 transactions, worth $4.97M in total on Nov 5, 2026. Shares held after the trade: 45,172 (-2.4%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.72M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $598.68 to $605.97 a share (average $601.92) in 8 transactions, worth $5.72M in total on Nov 3, 2026. Shares held after the trade: 324,443 (-0.0%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.66M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $593.09 to $598.84 a share (average $596.22) in 7 transactions, worth $5.66M in total on Nov 2, 2026. Shares held after the trade: 324,443 (-0.1%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.7M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $594.92 to $608.05 a share (average $600.09) in 13 transactions, worth $5.7M in total on Oct 30, 2026. Shares held after the trade: 324,443 (-0.0%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.65M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $590.43 to $599.30 a share (average $594.78) in 9 transactions, worth $5.65M in total on Oct 29, 2026. Shares held after the trade: 324,443 (-0.0%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.56M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $583.50 to $588.39 a share (average $585.49) in 6 transactions, worth $5.56M in total on Oct 28, 2026. Shares held after the trade: 324,443 (-0.0%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.58M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $582.66 to $592.84 a share (average $587.73) in 11 transactions, worth $5.58M in total on Oct 27, 2026. Shares held after the trade: 324,443 (-0.0%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.59M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $585.71 to $592.92 a share (average $588.64) in 8 transactions, worth $5.59M in total on Oct 26, 2026. Shares held after the trade: 324,443 (-0.2%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.54M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $577.68 to $588.00 a share (average $582.76) in 11 transactions, worth $5.54M in total on Oct 23, 2026. Shares held after the trade: 324,443 (-0.2%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.54M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $562.97 to $590.40 a share (average $583.38) in 21 transactions, worth $5.54M in total on Oct 22, 2026. Shares held after the trade: 324,443 (-0.0%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.32M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $552.52 to $566.43 a share (average $560.07) in 14 transactions, worth $5.32M in total on Oct 21, 2026. Shares held after the trade: 324,443 (-0.0%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.26M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $546.84 to $563.56 a share (average $553.87) in 17 transactions, worth $5.26M in total on Oct 20, 2026. Shares held after the trade: 324,443 (-0.1%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.16M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $534.75 to $556.88 a share (average $543.32) in 19 transactions, worth $5.16M in total on Oct 19, 2026. Shares held after the trade: 324,443 (-0.0%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.08M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $530.48 to $543.85 a share (average $534.66) in 13 transactions, worth $5.08M in total on Oct 16, 2026. Shares held after the trade: 324,443 (-0.0%).